Paid Clinical Trials in South Carolina
Here are the 6 most popular medical studies in Paid Studies South Carolina
Tyrosine Kinase Inhibitor
Selpercatinib for Non-Small Cell Lung Cancer
Recruiting1 awardPhase 2
Savannah, Georgia
This trial will study how well selpercatinib works in treating patients with RET fusion-positive non-small cell lung cancer. Selpercatinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.
Popular filter options for Paid Studies South Carolina trials
Phase 3 Clinical Trials
View 100 phase 3 medical studies.
Monoclonal Antibodies
Telisotuzumab Vedotin vs Docetaxel for Non-Small Cell Lung Cancer
Recruiting2 awardsPhase 3
Ypsilanti, Michigan
This trial is assessing whether telisotuzumab vedotin is more effective than docetaxel and to evaluate the safety of telisotuzumab vedotin in adult patients with NSCLC who have previously been treated.
Monoclonal Antibodies
Litifilimab for Lupus
Recruiting1 awardPhase 3
Wilmington, North Carolina
“ I wanna put effort into helping research options in all regards to Lupus. If this is something one day we can prevent or cure for other generations so they don't have to go thru the same things I have then I wanna do all that I can.”
PatientReceived 2+ prior treatments
BI 1015550 for Interstitial Lung Disease
Recruiting1 awardPhase 3
Charleston, South Carolina
This trialis testing a medicine to help people with Progressive Fibrosing Interstitial Lung Diseases. Participants take tablets and visit the study site for up to two and a half years for regular tests and checkups.
Clinical Trials With No Placebo
View 100 medical studies that do not have a placebo group.
Endocrine Drug Therapy
Hormone Therapy for Breast Cancer
Recruiting1 award15 criteria
Fort Gordon, Georgia
This trial will determine if asking about symptoms more often helps young women stay on hormone therapy for breast cancer, reducing side effects and increasing their chances of a successful treatment.
Monoclonal Antibodies
Telisotuzumab Vedotin vs Docetaxel for Non-Small Cell Lung Cancer
Recruiting2 awardsPhase 3
Ypsilanti, Michigan
This trial is assessing whether telisotuzumab vedotin is more effective than docetaxel and to evaluate the safety of telisotuzumab vedotin in adult patients with NSCLC who have previously been treated.
Platinum-based Chemotherapy
Carboplatin + Paclitaxel + Ramucirumab for Thymic Cancer
Recruiting1 awardPhase 2
Corbin, Kentucky
“ I've done chemo, had surgery and radiation, but my cancer has returned. I am currently take 10mg of Everolimus daily, but would like to know if there are other treatments.”
PatientReceived 1 prior treatment
View More Paid Studies South Carolina Trials
See another 83 many medical studies focused on Paid Studies South Carolina.
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.